These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20672374)

  • 1. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases.
    Scott SA; Edelmann L; Liu L; Luo M; Desnick RJ; Kornreich R
    Hum Mutat; 2010 Nov; 31(11):1240-50. PubMed ID: 20672374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive population screening in the Ashkenazi Jewish population for recurrent disease-causing variants.
    Shi L; Webb BD; Birch AH; Elkhoury L; McCarthy J; Cai X; Oishi K; Mehta L; Diaz GA; Edelmann L; Kornreich R
    Clin Genet; 2017 Apr; 91(4):599-604. PubMed ID: 27415407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premarital and prenatal screening for cystic fibrosis: experience in the Ashkenazi Jewish population.
    Kornreich R; Ekstein J; Edelmann L; Desnick RJ
    Genet Med; 2004; 6(5):415-20. PubMed ID: 15371906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.
    Edelmann L; Dong J; Desnick RJ; Kornreich R
    Am J Hum Genet; 2002 Apr; 70(4):1023-7. PubMed ID: 11845410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
    Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
    Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of carrier frequencies utilizing the gnomAD database for ACMG recommended carrier screening and Finnish disease heritage conditions in non-Finnish European, Finnish, and Ashkenazi Jewish populations.
    Kandolin M; Pöyhönen M; Jakkula E
    Am J Med Genet A; 2024 Jul; 194(7):e63588. PubMed ID: 38459613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities.
    Hoffman JD; Park JJ; Schreiber-Agus N; Kornreich R; Tanner AK; Keiles S; Friedman KJ; Heim RA
    Prenat Diagn; 2014 Dec; 34(12):1161-7. PubMed ID: 24996053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.
    Ferreira JC; Schreiber-Agus N; Carter SM; Klugman S; Gregg AR; Gross SJ
    Am J Obstet Gynecol; 2014 Sep; 211(3):197-204. PubMed ID: 24508465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal genetic screening in the Ashkenazi Jewish population.
    Zinberg RE; Kornreich R; Edelmann L; Desnick RJ
    Clin Perinatol; 2001 Jun; 28(2):367-82. PubMed ID: 11499058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendation of premarital genetic screening in the Syrian Jewish community based on mutation carrier frequencies within Syrian Jewish cohorts.
    Zeevi DA; Chung WK; Levi C; Scher SY; Bringer R; Kahan Y; Muallem H; Benel R; Hirsch Y; Weiden T; Ekstein A; Ekstein J
    Mol Genet Genomic Med; 2021 Aug; 9(8):e1756. PubMed ID: 34288589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening.
    Haque IS; Lazarin GA; Kang HP; Evans EA; Goldberg JD; Wapner RJ
    JAMA; 2016 Aug; 316(7):734-42. PubMed ID: 27533158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from expanded reproductive carrier screening in self-reported Ashkenazi, Sephardi, and Mizrahi Jewish patients.
    Akler G; Birch AH; Schreiber-Agus N; Cai X; Cai G; Shi L; Yu C; Larmore AM; Mendiratta-Vij G; Elkhoury L; Dillon MW; Zhu J; Mclellan AS; Suer FE; Webb BD; Schadt EE; Kornreich R; Edelmann L
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1053. PubMed ID: 31880409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded genetic screening panel for the Ashkenazi Jewish population.
    Baskovich B; Hiraki S; Upadhyay K; Meyer P; Carmi S; Barzilai N; Darvasi A; Ozelius L; Peter I; Cho JH; Atzmon G; Clark L; Yu J; Lencz T; Pe'er I; Ostrer H; Oddoux C
    Genet Med; 2016 May; 18(5):522-8. PubMed ID: 26334176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pan-ethnic and ethnic-based carrier screening panels for individuals of Ashkenazi Jewish descent.
    Rosenblum LS; Zhu H; Zhou Z; Teicher J; Heim RA; Leach NT
    J Genet Couns; 2020 Feb; 29(1):56-66. PubMed ID: 31663226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular screening for diseases frequent in Ashkenazi Jews: lessons learned from more than 100,000 tests performed in a commercial laboratory.
    Strom CM; Crossley B; Redman JB; Quan F; Buller A; McGinniss MJ; Sun W
    Genet Med; 2004; 6(3):145-52. PubMed ID: 15354333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population.
    Ekstein J; Rubin BY; Anderson SL; Weinstein DA; Bach G; Abeliovich D; Webb M; Risch N
    Am J Med Genet A; 2004 Aug; 129A(2):162-4. PubMed ID: 15316959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.
    Eng CM; Desnick RJ
    Adv Genet; 2001; 44():275-96. PubMed ID: 11596990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.
    Balwani M; Fuerstman L; Kornreich R; Edelmann L; Desnick RJ
    Arch Intern Med; 2010 Sep; 170(16):1463-9. PubMed ID: 20837833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.
    Edelmann L; Wasserstein MP; Kornreich R; Sansaricq C; Snyderman SE; Diaz GA
    Am J Hum Genet; 2001 Oct; 69(4):863-8. PubMed ID: 11509994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.